00767.HK
Zhong Ji Longevity Science Group Limited
HKSE · Financial Services · Financial - Credit Services · HK
HKD 0.48
+7.87%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 364.2M | 165.2M | 168.6M | 65.0M | 89.4M |
| Cost of Revenue | 305.3M | 148.4M | 111.2M | 8.7M | 10.0M |
| Gross Profit | 196.1M | 16.7M | 57.4M | 56.3M | 79.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 99.1M | 48.8M | 82.7M | 75.2M | 44.0M |
| General & Admin Expense | 91.2M | 44.6M | 66.4M | 69.5M | 41.1M |
| Selling & Marketing Expense | 8.0M | 4.2M | 16.3M | 5.7M | 2.8M |
| Other Expenses | 15.5M | (9.9M) | — | 24.0K | 34.7M |
| Total Operating Expenses | 114.6M | 38.9M | 82.7M | 75.3M | 78.7M |
| Cost and Expenses | 282.8M | 187.3M | 191.6M | 84.0M | 77.7M |
| Operating Income (EBIT) | 81.5M | (22.1M) | 85.9M | (15.5M) | 11.8M |
| Non-Operating | |||||
| Interest Income | 24.7M | 26.2M | 1.1M | 132.0K | 144.0K |
| Interest Expense | 248.0K | 969.0K | 1.6M | 1.9M | 417.0K |
| Net Interest Income | 24.4M | 25.2M | (438.0K) | (1.8M) | (273.0K) |
| Other Non-Op Income/Expense | (133.8M) | 8.7M | (119.1M) | 29.4M | (2.5M) |
| Non-Operating Income (excl Interest) | 109.1M | (8.7M) | 115.9M | (22.2M) | 2.4M |
| EBT (Pre-Tax Income) | (52.4M) | (13.5M) | (33.2M) | 4.7M | 9.3M |
| Income Tax Expense | 4.3M | 3.0M | 1.6M | 2.2M | 8.6M |
| Bottom Line | |||||
| Net Income | (57.1M) | (16.8M) | (34.7M) | 2.3M | (904.0K) |
| Earnings from Cont. Ops | (56.7M) | (16.4M) | (34.8M) | 2.5M | 701.0K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (57.0M) | (16.8M) | (34.7M) | 2.3M | (904.0K) |
| Per Share | |||||
| Basic EPS | (HK$0.10) | (HK$0.03) | (HK$0.07) | HK$0.00 | (HK$0.00) |
| Diluted EPS | (HK$0.10) | (HK$0.03) | (HK$0.07) | HK$0.00 | (HK$0.00) |
| Revenue Per Share | HK$0.57 | HK$0.28 | HK$0.33 | HK$0.04 | HK$0.06 |
| Shares | |||||
| Basic Shares Outstanding | 636.7M | 593.4M | 507.3M | 1.5B | 1.5B |
| Diluted Shares Outstanding | 636.7M | 593.4M | 507.3M | 1.5B | 1.5B |
| Profitability Metrics | |||||
| EBITDA | (19.5M) | (7.4M) | (23.1M) | 13.0M | 16.0M |
| D&A | 11.7M | 6.1M | 6.9M | 7.3M | 4.2M |
| EBIT | (27.7M) | (13.5M) | (30.0M) | 5.7M | 11.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026